Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 600 contracts
Sources: Sales Agreement (Strive, Inc.), Capital on Demand Sales Agreement (Armata Pharmaceuticals, Inc.), Sales Agreement (Synergy CHC Corp.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 376 contracts
Sources: Underwriting Agreement (Camp4 Therapeutics Corp), Underwriting Agreement (Kyverna Therapeutics, Inc.), Underwriting Agreement (Kodiak Sciences Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 257 contracts
Sources: Atm Sales Agreement (Volato Group, Inc.), Sales Agreement (Agriforce Growing Systems Ltd.), Sales Agreement (XOMA Royalty Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Units nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 136 contracts
Sources: Underwriting Agreement (Trailblazer Merger Corp I), Underwriting Agreement (Trailblazer Merger Corp I), Underwriting Agreement (PROTONIQ Acquisition Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 132 contracts
Sources: Open Market Sale Agreement (Black Diamond Therapeutics, Inc.), At the Market Sales Agreement (Oncolytics Biotech Inc), At the Market Sales Agreement (Better Home & Finance Holding Co)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Time of Sale Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 122 contracts
Sources: Underwriting Agreement (Eastman Chemical Co), Underwriting Agreement (Service Corp International), Underwriting Agreement (Eastman Chemical Co)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Time of Sale Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 106 contracts
Sources: Underwriting Agreement (Mercadolibre Inc), Underwriting Agreement (Bowhead Specialty Holdings Inc.), Underwriting Agreement (Eagle Materials Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Time of Sale Information and the Prospectus Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 95 contracts
Sources: Purchase Agreement (Aris Water Solutions, Inc.), Purchase Agreement (Matthews International Corp), Purchase Agreement (Group 1 Automotive Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Offered Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 71 contracts
Sources: Underwriting Agreement (Fennec Pharmaceuticals Inc.), Underwriting Agreement (Satellogic Inc.), Underwriting Agreement (AIRO Group Holdings, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Time of Sale Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 58 contracts
Sources: Underwriting Agreement (Amag Pharmaceuticals Inc.), Underwriting Agreement (Seattle Genetics Inc /Wa), Underwriting Agreement (Avalonbay Communities Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement Time of Sale Information and the Prospectus Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 48 contracts
Sources: Purchase Agreement (Lyft, Inc.), Purchase Agreement (Lyft, Inc.), Purchase Agreement (Semtech Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus Commission Documents will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 41 contracts
Sources: Common Stock Purchase Agreement (Digital Ally, Inc.), Ordinary Share Purchase Agreement (Blue Gold LTD), Ordinary Share Purchase Agreement (Blue Gold LTD)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Public Units nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 40 contracts
Sources: Underwriting Agreement (Horizon Space Acquisition I Corp.), Underwriting Agreement (Horizon Space Acquisition I Corp.), Underwriting Agreement (Lakeshore Acquisition II Corp.)
Margin Rules. Neither the issuance, sale sale, and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U U, or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 39 contracts
Sources: At the Market Issuance Sales Agreement (ENDRA Life Sciences Inc.), At the Market Issuance Sales Agreement (Auddia Inc.), At the Market Issuance Sales Agreement (bioAffinity Technologies, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Final Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 38 contracts
Sources: Underwriting Agreement (APRINOIA Therapeutics Inc.), Underwriting Agreement (SMJ International Holdings Inc.), Underwriting Agreement (Papa Medical Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 37 contracts
Sources: Open Market Sale Agreement (Kyverna Therapeutics, Inc.), Open Market Sale Agreement (Metagenomi, Inc.), Sales Agreement (SpringWorks Therapeutics, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 35 contracts
Sources: Placement Agent Agreement (Satellogic Inc.), Underwriting Agreement (Black Diamond Therapeutics, Inc.), Underwriting Agreement (South Jersey Industries Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 31 contracts
Sources: Sales Agreement (PolyPid Ltd.), Sales Agreement (InflaRx N.V.), Sales Agreement (Crinetics Pharmaceuticals, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 31 contracts
Sources: Underwriting Agreement (Veru Inc.), Securities Purchase Agreement (Gorilla Technology Group Inc.), Underwriting Agreement (Ur-Energy Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 28 contracts
Sources: Purchase Agreement, Purchase Agreement (Bill Barrett Corp), Purchase Agreement (McMoran Exploration Co /De/)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Final Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 23 contracts
Sources: Underwriting Agreement (Innovation Beverage Group LTD), Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (Innovation Beverage Group LTD)
Margin Rules. Neither the issuance, sale and delivery of the Placement Firm Shares and the Option Shares nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Final Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 23 contracts
Sources: Underwriting Agreement (Globavend Holdings LTD), Underwriting Agreement (Fd Technology Inc.), Underwriting Agreement (Fd Technology Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 23 contracts
Sources: Underwriting Agreement (Precision Biosciences Inc), Underwriting Agreement (IonQ, Inc.), Underwriting Agreement (Flux Power Holdings, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 18 contracts
Sources: Underwriting Agreement (Ares Management Corp), Underwriting Agreement (Rectitude Holdings Ltd.), Underwriting Agreement (Rectitude Holdings Ltd.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 15 contracts
Sources: Underwriting Agreement (Exzeo Group, Inc.), Underwriting Agreement (Hornbeck Offshore Services Inc /La), Underwriting Agreement (Nuvalent, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company Issuers as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 14 contracts
Sources: Underwriting Agreement (MPT Operating Partnership, L.P.), Underwriting Agreement (MPT Operating Partnership, L.P.), Underwriting Agreement (MPT Operating Partnership, L.P.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described disclosed in each of the Time of Sale Information, the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 14 contracts
Sources: Underwriting Agreement (Air Lease Corp), Underwriting Agreement (Air Lease Corp), Underwriting Agreement (Air Lease Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the General Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 13 contracts
Sources: Underwriting Agreement (Ascendis Pharma a/S), International Underwriting Agreement (GDS Holdings LTD), Equity Distribution Agreement (Piedmont Office Realty Trust, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company Issuers as described in each of the Registration Statement Time of Sale Information and the Prospectus Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 13 contracts
Sources: Purchase Agreement (GoDaddy Inc.), Purchase Agreement (Enviva Partners, LP), Purchase Agreement (Enviva Partners, LP)
Margin Rules. Neither the issuance, sale and delivery of the Placement Company Firm Shares nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Final Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 13 contracts
Sources: Underwriting Agreement (Ultra High Point Holdings LTD), Underwriting Agreement (Magnitude International LTD), Underwriting Agreement (Delixy Holdings LTD)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 12 contracts
Sources: Underwriting Agreement (Hycroft Mining Holding Corp), Open Market Sale Agreement (Achieve Life Sciences, Inc.), Open Market Sale Agreement (LIGHTBRIDGE Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the General Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 11 contracts
Sources: Underwriting Agreement (Dynex Capital Inc), Underwriting Agreement (Dynex Capital Inc), Underwriting Agreement (Transcept Pharmaceuticals Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus Commission Documents will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 10 contracts
Sources: Common Stock Purchase Agreement (Us Energy Corp), Common Stock Purchase Agreement (Blaize Holdings, Inc.), Ordinary Share Purchase Agreement (DDC Enterprise LTD)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Offered Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 10 contracts
Sources: Underwriting Agreement (Planet 13 Holdings Inc.), Underwriting Agreement (Zosano Pharma Corp), Underwriting Agreement
Margin Rules. Neither the issuance, sale and delivery of the Placement Common Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Prospectus and the Prospectus General Disclosure Package will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 10 contracts
Sources: Sales Agency Financing Agreement (Avalonbay Communities Inc), Sales Agency Financing Agreement (Avalonbay Communities Inc), Sales Agency Financing Agreement (Avalonbay Communities Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Time of Sale Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 9 contracts
Sources: Underwriting Agreement (T-Mobile US, Inc.), Underwriting Agreement (T-Mobile US, Inc.), Underwriting Agreement (T-Mobile US, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus Disclosure Documents will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 8 contracts
Sources: Chef Purchase Agreement (Movano Inc.), Chef Purchase Agreement (Hyperliquid Strategies Inc), Chef Purchase Agreement (Sonim Technologies Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Notes nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Time of Sale Prospectus and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 8 contracts
Sources: Underwriting Agreement (Avalonbay Communities Inc), Underwriting Agreement (Avalonbay Communities Inc), Underwriting Agreement (Avalonbay Communities Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus Prospectuses will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 7 contracts
Sources: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Aptose Biosciences Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the General Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 7 contracts
Sources: Underwriting Agreement (SoFi Technologies, Inc.), Underwriting Agreement (Intapp, Inc.), Underwriting Agreement (Palmer Square Capital BDC Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus General Disclosure Package will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 7 contracts
Sources: Distribution Agreement (Tellurian Inc. /De/), Distribution Agreement (Tellurian Inc. /De/), Distribution Agreement (Tellurian Inc. /De/)
Margin Rules. Neither the issuance, sale and delivery of the Placement Rights or the Shares in connection with Rights Offering or the sale of the Investor Shares nor the application of the proceeds thereof by the Company as to be described in the Rights Offering Registration Statement and the Rights Offering Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 7 contracts
Sources: Equity Purchase and Commitment Agreement (Hli Operating Co Inc), Equity Purchase and Commitment Agreement (Highland Capital Management Lp), Equity Purchase and Commitment Agreement (Delphi Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Offered Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the General Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 7 contracts
Sources: Underwriting Agreement (AxoGen, Inc.), Underwriting Agreement (Aastrom Biosciences Inc), Underwriting Agreement (MeetMe, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Offered Securities nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Underwriting Agreement (Biomea Fusion, Inc.), Underwriting Agreement (Biomea Fusion, Inc.), Underwriting Agreement (Biomea Fusion, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Sales Agreement (Olema Pharmaceuticals, Inc.), Sales Agreement (Olema Pharmaceuticals, Inc.), Sales Agreement (Olema Pharmaceuticals, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company Issuer as described in the Registration Statement each of Pricing Prospectus and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Underwriting Agreement (American Homes 4 Rent, L.P.), Underwriting Agreement (American Homes 4 Rent, L.P.), Underwriting Agreement (American Homes 4 Rent, L.P.)
Margin Rules. Neither To the Company’s knowledge, neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Capital on Demand Sales Agreement (Monopar Therapeutics), Capital on Demand Sales Agreement (Aileron Therapeutics Inc), Capital on Demand Sales Agreement (ARCA Biopharma, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation Regulations T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 6 contracts
Sources: At Market Issuance Sales Agreement (Umh Properties, Inc.), At Market Issuance Sales Agreement (Umh Properties, Inc.), At Market Issuance Sales Agreement (Monmouth Real Estate Investment Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and Statement, the Prospectus or any Permitted Free Writing Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Equity Distribution Agreement (Medical Properties Trust Inc), Equity Distribution Agreement (Medical Properties Trust Inc), Equity Distribution Agreement (Medical Properties Trust Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the General Disclosure Package and the Final Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Placement Agency Agreement (SilverSun Technologies, Inc.), Placement Agency Agreement (Nac Global Technologies, Inc.), Placement Agency Agreement (Cytosorbents Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Notes nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Underwriting Agreement (Church & Dwight Co Inc /De/), Underwriting Agreement (Church & Dwight Co Inc /De/), Underwriting Agreement (Church & Dwight Co Inc /De/)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement Pricing Prospectus and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Underwriting Agreement (Keysight Technologies, Inc.), Underwriting Agreement (Keysight Technologies, Inc.), Underwriting Agreement (Keysight Technologies, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Securities or the Underlying Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the ADR Registration Statement, the Pricing Disclosure Package, the Prospectus and the ADR Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (DoubleDown Interactive Co., Ltd.), Underwriting Agreement (DoubleDown Interactive Co., Ltd.), Underwriting Agreement (DoubleDown Interactive Co., Ltd.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (Aveo Pharmaceuticals Inc), Underwriting Agreement (NPS Pharmaceuticals Inc), Underwriting Agreement (Aveo Pharmaceuticals Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Securities Purchase Agreement (NeurogesX Inc), Securities Purchase Agreement (Ada-Es Inc), Company Stock Purchase Agreement (Tracinda Corp)
Margin Rules. Neither the issuance, sale and delivery of any of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 4 contracts
Sources: At the Market Sales Agreement (reAlpha Tech Corp.), At Market Issuance Sales Agreement (AEye, Inc.), At Market Issuance Sales Agreement (Soligenix, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 4 contracts
Sources: Sales Agreement (Relay Therapeutics, Inc.), At the Market Sales Agreement (Aridis Pharmaceuticals, Inc.), Sales Agreement (Aridis Pharmaceuticals, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and or the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: At Market Issuance Sales Agreement (Bitdeer Technologies Group), At Market Issuance Sales Agreement (Bitdeer Technologies Group), At Market Issuance Sales Agreement (Bitdeer Technologies Group)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares ADSs nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Atm Sales Agreement (Safe-T Group Ltd.), Sales Agreement (Gracell Biotechnologies Inc.), Equity Distribution Agreement (Kazia Therapeutics LTD)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares by the Company nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Open Market Sales Agreement (IDEAYA Biosciences, Inc.), Open Market Sales Agreement (IDEAYA Biosciences, Inc.), Open Market Sale Agreement (IDEAYA Biosciences, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Firm Shares nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Final Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (SAG Holdings LTD), Underwriting Agreement (SAG Holdings LTD), Underwriting Agreement (SAG Holdings LTD)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Offered Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Placement Agent Agreement (Tellurian Inc. /De/), Placement Agent Agreement (Tellurian Inc. /De/), Placement Agent Agreement (Tellurian Inc. /De/)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Final Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (Wj Communications Inc), Underwriting Agreement (Lexar Media Inc), Underwriting Agreement (Collins & Aikman Products Co)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof received by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Sales Agreement (Inventiva S.A.), Sales Agreement (Inventiva S.A.), Sales Agreement (Inventiva S.A.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares pursuant to this Agreement nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate constitute a violation by the Company of Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (Xoma LTD /De/), At Market Issuance Sales Agreement (Xoma LTD /De/), At Market Issuance Sales Agreement (Xoma LTD /De/)
Margin Rules. Neither With respect to the Placement Shares, neither the issuance, sale and or delivery of the Placement Shares thereof, nor the application of the proceeds thereof therefrom, by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (CNB Financial Corp/Pa), At Market Issuance Sales Agreement (CNB Financial Corp/Pa), At Market Issuance Sales Agreement (City Holding Co)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Notes nor the application of the proceeds thereof by the Company as described in the Registration Statement Time of Sale Prospectus and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Distribution Agreement (Avalonbay Communities Inc), Terms Agreement (Avalonbay Communities Inc), Distribution Agreement (Avalonbay Communities Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Rights or the Shares nor the application of the proceeds thereof by the Company as to be described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Equity Commitment Agreement (Owens Corning), Equity Commitment Agreement (Owens Corning), Equity Commitment Agreement (Owens Corning)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the U.S. Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Sales Agreement (GREENPOWER MOTOR Co INC.), Sales Agreement (Theratechnologies Inc.), Sales Agreement (Correvio Pharma Corp.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Prospectus and the Prospectus Time of Sale Information will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Sales Agreement (Solid Biosciences Inc.), Sales Agreement (Solid Biosciences Inc.), Sales Agreement (Solid Biosciences Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Offered Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Final Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Placement Agent Agreement (Velo3D, Inc.), Placement Agent Agreement (Velo3D, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus thereof, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Ariad Pharmaceuticals Inc), Underwriting Agreement (Ariad Pharmaceuticals Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (GDEV Inc.), Sales Agreement (Addex Therapeutics Ltd.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Offered Securities nor the application of the proceeds thereof received by the Company as described in the Registration Statement Statement, the Statutory Prospectus and the Final Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (SOC Telemed, Inc.), Underwriting Agreement (SOC Telemed, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Ormat Technologies, Inc.), Underwriting Agreement (Ormat Technologies, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Preferred Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus Filed SEC Reports will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Securities Purchase and Exchange Agreement (Interpace Biosciences, Inc.), Securities Purchase Agreement (Interpace Diagnostics Group, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Asterias Biotherapeutics, Inc.), Underwriting Agreement (Biotime Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof Net Proceeds by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (Terns Pharmaceuticals, Inc.), Sales Agreement (Terns Pharmaceuticals, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Anworth Mortgage Asset Corp), Underwriting Agreement (Peregrine Pharmaceuticals Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Units nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Jack Creek Investment Corp.), Underwriting Agreement (Jack Creek Investment Corp.)
Margin Rules. Neither the issuanceoffering, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (SOPHiA GENETICS SA), Sales Agreement (SOPHiA GENETICS SA)
Margin Rules. Neither the issuance, sale and delivery of the Placement Rights or the Shares in connection with Rights Offering or the sale of the Investor Shares nor the application of the proceeds thereof by the Company as described and to be described in the Rights Offering Registration Statement and the Rights Offering Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Equity Purchase and Commitment Agreement (Delphi Corp), Equity Purchase and Commitment Agreement (Appaloosa Management Lp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Underlying Ordinary Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (Innate Pharma SA), Sales Agreement (Innate Pharma SA)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (Bionomics Limited/Fi), Sales Agreement (Bionomics Limited/Fi)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement Statements and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Serologicals Corp), Underwriting Agreement (Myriad Genetics Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Public Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Zosano Pharma Corp), Underwriting Agreement (Zosano Pharma Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Tenneco Inc), Underwriting Agreement (Tenneco Automotive Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, any Permitted Free Writing Prospectus and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Distribution Agreement (Axon Enterprise, Inc.), Distribution Agreement (Axon Enterprise, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors..
Appears in 2 contracts
Sources: Sales Agreement (Cassava Sciences Inc), Capital on Demand Sales Agreement (Pain Therapeutics Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Firm Shares and the Option Securities nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Final Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Volcon, Inc.), Underwriting Agreement (Volcon, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds received thereof by the Company as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Aptinyx Inc.), Underwriting Agreement (Aptinyx Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 2 contracts
Sources: Underwriting Agreement (Sunnova Energy International Inc.), Underwriting Agreement (Sunnova Energy International Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares to be sold by the Company nor the application of the proceeds thereof by the Company as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Trean Insurance Group, Inc.), Underwriting Agreement (Trean Insurance Group, Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Ordinary Shares nor the application of the proceeds thereof by the Company Company, in each case, as described in the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus Prospectus, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Agroz Inc.), Underwriting Agreement (Agroz Inc.)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate or result in a violation of Regulation TT (12 C.F.R. Part 220), Regulation U (12 C.F.R. Part 221) or Regulation X (12 C.F.R. Part 224) of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 1 contract
Sources: At Market Issuance Sales Agreement (Peabody Energy Corp)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Transactions nor the application of the proceeds thereof by the Company as described in each of the Registration Statement Statement, the Offering Materials and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Dealer Manager and Subscription Agent Agreement (BioNTech SE)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Company Shares, if any, nor the application of the proceeds thereof from the sale of any such Shares or from the settlement of the Forward Sale Agreement or any Additional Forward Sale Agreement, as the case may be, by the Company as described in the Registration Statement Statement, the Time of Sale Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares Securities and the PIPE Securities nor the application of the proceeds thereof by the Company Company, in the case of the Shares only, as described in each of the Registration Statement Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. Neither the issuance, sale and delivery of the Placement Rights or the Shares nor the application of the proceeds thereof by the Company as to be described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Commitment Agreement (Solutia Inc)
Margin Rules. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Sales Agreement (OceanPal Inc.)